2919-06-4

Downstream Products

• 88830-59-5 3-Bromo-6-(toluene-4-sulfonyl)-hexa-3,4-dien-2-ol 
• 88830-60-8 5-Bromo-6-(toluene-4-sulfonyl)-hex-3-yn-2-ol 
• 85019-47-2 6-Benzenesulfonyl-3-chloro-hexa-3,4-dien-2-ol 
• 85019-46-1 6-Benzenesulfonyl-5-chloro-hex-3-yn-2-ol 
• 85019-52-9 (E)-6-(Toluene-4-sulfonyl)-hex-5-en-3-yn-2-ol 
• 85019-48-3 5-Chloro-6-(toluene-4-sulfonyl)-hex-3-yn-2-ol 
• 3280-52-2 ((2E,4E)-4-Hexa-2,4-dienyl)-phenol 
• 3280-61-3 6-Hydroxy-1-methyl-3-hexyl-benzol 
• 3280-62-4 4-n-Hexyl-m-kresol 
• 3280-54-4 4-((2E,4E)-Hexa-2,4-dienyl)-3-methyl-phenol 
• 3280-58-8 1-((2E,4E)-Hexa-2,4-dienyl)-4-methoxy-benzene 
• 3280-53-3 4-((2E,4E)-Hexa-2,4-dienyl)-2-methyl-phenol 
• 3280-59-9 4-((2E,4E)-Hexa-2,4-dienyl)-1-methoxy-2-methyl-benzene 
• 3555-16-6 1-((2E,4E)-Hexa-2,4-dienyl)-4-methoxy-2-methyl-benzene 

Relevant academic research and scientific papers

SUBSTITUTED IMIDAZOLECARBOXYLATE DERIVATIVES AND THE USE THEREOF

A compound is shown in formula (I). The derivatives of the compound include a stereoisomer, a pharmaceutically acceptable salt, a solvate, a prodrug, a metabolite, a deuterated derivative. The compound is a structurally novel substituted imidazole formate derivative. Substituted imidazole formate derivatives are used in preparing a drug with sedative, hypnotic and/or anesthetic effects, as well as a drug that can control the state of epilepsy. The compound has a good inhibitory effect on the central nervous system, and provides a new option for clinical screening of and/or preparation of a drug with sedative, hypnotic and/or anesthetic effects and controlling the state of epilepsy.